IDEAYA Biosciences (IDYA) Other Working Capital Changes (2018 - 2026)

IDEAYA Biosciences (IDYA) reported Other Working Capital Changes of -$587000.0 for Q1 2026, up 59.21% sequentially from -$1.4 million in Q4 2023.

IDEAYA Biosciences (IDYA) Other Working Capital Changes (2018 - 2026) Analysis & Trends

IDEAYA Biosciences (IDYA) has 5 years of Other Working Capital Changes data on file, last reported at -$587000.0 in Q1 2026.

For the quarter ending Q1 2026, Other Working Capital Changes changed N/A year-over-year to -$587000.0; the trailing twelve-month figure through Mar 2026 stood at -$587000.0 (up 59.21% YoY), and the FY2023 full-year result was -$13.8 million, up 70.41% from the prior year.
Other Working Capital Changes rose to -$587000.0 in Q1 2026, from -$1.4 million in the prior quarter.
In the past five years, Other Working Capital Changes ranged from a high of $3.9 million in Q2 2023 to a low of -$4.1 million in Q2 2024.
A 5-year average of $124764.7 and a median of -$192000.0 in 2025 frame the typical range for Other Working Capital Changes.
Across the five-year window, Other Working Capital Changes slumped 230.44% in 2022 and jumped 94.76% in 2023, its largest moves.
Tracing IDYA's Other Working Capital Changes over 3 years: stood at -$3.8 million in 2022, then jumped by 62.41% to -$1.4 million in 2023, then soared by 59.21% to -$587000.0 in 2026.
Business Quant data shows IDYA's Other Working Capital Changes at -$587000.0 in Q1 2026, -$1.4 million in Q4 2023, and -$1.4 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	IDEAYA Biosciences	3.21 Bn	2.54 Bn	-

Download Data